Cargando…

Kratom-Induced Cholestatic Liver Injury Mimicking Anti-Mitochondrial Antibody-Negative Primary Biliary Cholangitis: A Case Report and Review of Literature

Kratom is an herbal supplement used to relieve chronic pain or opioid withdrawal symptoms. Recent news articles covering adverse effects associated with kratom use have brought attention to its organ toxicities. Reports of kratom-induced hepatic toxicity are limited and only three case reports of kr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aldyab, Mahmoud, Ells, Peter F., Bui, Rosa, Chapman, Timothy D., Lee, Hwajeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731044/ https://www.ncbi.nlm.nih.gov/pubmed/31523332 http://dx.doi.org/10.14740/gr1204

Ejemplares similares

Kratom induced severe cholestatic liver injury histologically mimicking primary biliary cholangitis: A case report
por: Gandhi, Darshan, et al.
Publicado: (2020)

Cholestatic Pruritus Treatments in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Systematic Literature Review
por: Smith, Helen T., et al.
Publicado: (2023)

Primary hepatic sarcoidosis presenting with cholestatic liver disease and mimicking primary biliary cholangitis: a case report
por: Park, Young Joo, et al.
Publicado: (2021)

Kratom-Induced Cholestatic Liver Injury and Its Conservative Management
por: Fernandes, Christopher T., et al.
Publicado: (2019)

Distinction between Mitochondrial Antibody-Positive and -Negative Primary Biliary Cholangitis
por: Matli, Venkata Vinod Kumar, et al.
Publicado: (2023)

Pilot study with IBAT inhibitor A4250 for the treatment of cholestatic pruritus in primary biliary cholangitis
por: Al-Dury, Samer, et al.
Publicado: (2018)

Mitochondrial Mutations in Cholestatic Liver Disease with Biliary Atresia
por: Koh, Hong, et al.
Publicado: (2018)

Antimitochondrial Antibody-Negative Primary Biliary Cholangitis: A Retrospective Diagnosis
por: Al-Handola, Rami, et al.
Publicado: (2023)

Meta-Analysis of Antinuclear Antibodies in the Diagnosis of Antimitochondrial Antibody-Negative Primary Biliary Cholangitis
por: Zhang, Qian, et al.
Publicado: (2019)

Inflammatory Myopathy Associated with Anti-mitochondrial Antibody-negative Primary Biliary Cholangitis Diagnosed by a Liver Biopsy
por: Kainaga, Mitsuhiro, et al.
Publicado: (2022)

Composite intestinal adenoma-microcarcinoid: An update and literature review
por: Fu, Zhi-Yan, et al.
Publicado: (2021)

Kratom-Associated Mixed Cholestatic-Hepatocellular Liver Injury in a Patient With Long COVID: A case Report
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2022)

Benign vs malignant pancreatic lesions: Molecular insights to an ongoing debate
por: Aldyab, Mahmoud, et al.
Publicado: (2021)

Negative conversion of antimitochondrial antibody in primary biliary cirrhosis: a case of autoimmune cholangitis.
por: Cho, Y. J., et al.
Publicado: (1999)

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021)

Enhanced expression of miR-21 and miR-150 is a feature of anti-mitochondrial antibody-negative primary biliary cholangitis
por: Wasik, Urszula, et al.
Publicado: (2020)

A case of cholestatic hepatitis associated with histologic features of acute cholangitis
por: Takeuchi, Hajime, et al.
Publicado: (2011)

The Harm in Kratom
por: Drago, Joshua Z., et al.
Publicado: (2017)

Osteoporosis in primary biliary cholangitis
por: Danford, Christopher J, et al.
Publicado: (2018)

Baricitinib and primary biliary cholangitis
por: Gordon, Stuart C., et al.
Publicado: (2021)

Diagnostic value of anti-mitochondrial antibody in patients with primary biliary cholangitis: A systemic review and meta-analysis
por: Xu, Qingling, et al.
Publicado: (2023)

Antimitochondrial antibody associated with liver cirrhosis in patients with primary biliary cholangitis
por: Jin, Yujiao, et al.
Publicado: (2023)

Role of biliary tract cytology in the evaluation of extrahepatic cholestatic jaundice
por: Gupta, Mamta, et al.
Publicado: (2013)

Subclinical focal Cholangitis mimicking liver metastasis in asymptomatic patients with history of pancreatic Ductal Adenocarcinoma and Biliary tree intervention
por: Horvat, Natally, et al.
Publicado: (2017)

Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population
por: Alomari, Mohammad, et al.
Publicado: (2019)

Overlap Syndrome between Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Sundaram, Sridhar, et al.
Publicado: (2018)

Extrahepatic Manifestations of Primary Biliary Cholangitis
por: Chalifoux, Sara L, et al.
Publicado: (2017)

Obeticholic acid for primary biliary cholangitis
Publicado: (2020)

Current understanding of primary biliary cholangitis
por: Tanaka, Atsushi
Publicado: (2021)

Primary biliary cholangitis: pathogenic mechanisms
por: Prieto, Jesús, et al.
Publicado: (2021)

The Role of Epigenetics in Primary Biliary Cholangitis
por: Gerussi, Alessio, et al.
Publicado: (2022)

Obeticholic Acid for Primary Biliary Cholangitis
por: Floreani, Annarosa, et al.
Publicado: (2022)

Timing of biliary decompression for acute cholangitis
por: Yang, Jian, et al.
Publicado: (2023)

Risk Stratification in Primary Biliary Cholangitis
por: Martini, Francesco, et al.
Publicado: (2023)

Predicting Risk in Primary Biliary Cholangitis
por: Cho, Eun Ju
Publicado: (2023)

The Potential for Kratom as an Antidepressant and Antipsychotic
por: Johnson, Lindsay E., et al.
Publicado: (2020)

Increased microfilaments in hepatocytes and biliary ductular cells in cholestatic liver diseases.
por: Chung, Kyu-Won, et al.
Publicado: (2002)

Evaluation of Inhibitory Antibodies against the Muscarinic Acetylcholine Receptor Type 3 in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Wilde, Anne-Christin Beatrice, et al.
Publicado: (2022)

Poor performance of anti-mitochondrial antibodies for the diagnosis of primary biliary cholangitis in female Colombian patients: A single-center study
por: Guatibonza-García, Valentina, et al.
Publicado: (2021)

The future risk of primary biliary cholangitis (PBC) is low among patients with incidental anti‐mitochondrial antibodies but without baseline PBC
por: Duan, Weijia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ebqm45047q1cadaajalapj09e1